Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
Recent findings at the University of Pittsburgh School of Medicine are unraveling how RNA molecules influence prostate cancer progression. Bino John, PhD, an adjunct professor at Pittsburgh School of Medicine, ... Read more
Prostate cancer that metastasizes to the bone may be curable in the future using new research from the Pharmacology Department at Indiana University School of Medicine. Theresa A. Guise, MD, ... Read more
In terms of early prostate cancer detection methods, more is better. Researchers at Pacific Northwest National Laboratory in Richland, Washington determined that the ETS-related gene (ERG) is a reliable biomarker for ... Read more
Findings from the “Early Onset Prostate Cancer” project, conducted by a collaboration among the German Cancer Research Center, the University of Zurich, Hamburg-Eppendorf University Hospital, Heidelberg University, and many others, ... Read more
Testosterone, a hormone given to men with hypogonadism, does not appear to increase the risk of prostate cancer, despite concerns in the scientific community. Ahmad Haider, MD, PhD, a urologist ... Read more
When men are diagnosed with prostate cancer and have a life expectancy of less than 10 years, national guidelines recommend “watchful waiting” instead of treatment, as patients are unlikely to ... Read more
Research in the laboratory of Ulrich Rodeck, MD, PhD, at Thomas Jefferson University, is looking to make prostate cancer (and other cancer types) radiation therapy safer and more effective for ... Read more